Skip to main content
DIACEUTICS PLC logo

DIACEUTICS PLC — Investor Relations & Filings

Ticker · DXRX ISIN · GB00BJQTGV64 LEI · 213800VEWQBB39ZB8J81 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 277 across all filing types
Latest filing 2023-11-30 Remuneration Information
Country GB United Kingdom
Listing IL DXRX

About DIACEUTICS PLC

https://www.diaceutics.com/

Diaceutics PLC is a data analytics and end-to-end services provider focused on the development and commercialization of precision medicine diagnostics. The company supports pharmaceutical and biotech clients by providing solutions to improve the diagnostic testing ecosystem, aiming to ensure patients receive the correct personalized treatment. Its primary offering is DXRX, The Diagnostic Network®, a diagnostic commercialization platform for precision medicine. DXRX facilitates collaboration among stakeholders, including laboratories and pharmaceutical companies, in a secure marketplace and provides access to real-world diagnostic testing data. This integrated platform is designed to streamline the launch and adoption of new precision medicines.

Recent filings

Filing Released Lang Actions
PDMR Shareholding/Share Incentive Plan and TVR
Remuneration Information Classification · 99% confidence The document is an RNS announcement dated November 30, 2023, detailing share purchases and matched share awards for Persons Discharging Managerial Responsibilities (PDMRs) under a Share Incentive Plan (SIP). It explicitly mentions 'PDMR Shareholding/Share Incentive Plan' and includes tables structured according to Article 19(1) of Regulation (EU) No. 596/2014, which governs insider transactions. This type of filing, reporting personal share transactions by directors/executives, directly corresponds to the 'Director's Dealing' definition. The presence of the RNS Number and the reference to the FCA confirms it is a regulatory disclosure. Therefore, the correct classification is DIRS.
2023-11-30 English
Diaceutics to attend Stifel Conference in NYC
Report Publication Announcement Classification · 99% confidence The document is very short (2494 characters) and announces that company management will attend a specific conference ('Stifel 5th Annual 'Best of British' Discovery Conference'). It does not contain detailed financial results, audit opinions, or formal regulatory disclosures like a 10-K or IR. The presence of the RNS Number (9754U) and the distribution method ('This information is provided by Reach, the non-regulatory press release distribution service of RNS') strongly suggests it is a general regulatory announcement or press release that doesn't fit a more specific category like DIV, ER, or DIRS. Since it is a general announcement distributed via RNS that doesn't fit other specific categories (like management change, dividend, or capital change), the most appropriate fallback is Regulatory Filings (RNS).
2023-11-30 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is identified by the header 'RNS Number' and contains the standard format for 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, specifically detailing the acquisition or disposal of voting rights by a shareholder (Danske Bank A/S) in the issuer (Diaceutics PLC). This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-11-21 English
PDMR Shareholding/SIP & Total Voting Rights
Director's Dealing Classification · 99% confidence The document is titled 'PDMR Shareholding/Share Incentive Plan and Total Voting Rights' and details transactions made by Persons Discharging Managerial Responsibilities (PDMRs) concerning the purchase of ordinary shares and subsequent matched share awards under an Employee Benefit Trust/Share Incentive Plan (SIP). It explicitly references compliance with Article 19(1) of Regulation (EU) No. 596/2014, which governs insider transactions. This content directly corresponds to the definition of Director's Dealing (insider trades by executives). The RNS Number format and the mention of the London Stock Exchange further confirm it is a regulatory disclosure. Therefore, the appropriate code is DIRS.
2023-10-31 English
PDMR Shareholding/Share Incentive Plan and TVR
Director's Dealing Classification · 99% confidence The document is an RNS announcement (RNS Number : 8232P) dated October 11, 2023. The title explicitly mentions 'PDMR Shareholding/Share Incentive Plan' and details transactions made by Persons Discharging Managerial Responsibilities (PDMRs) regarding the purchase of ordinary shares and matched share awards under the Share Incentive Plan (SIP). This type of filing, reporting personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2023-10-11 English
Block Listing Application to AIM
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content announces an application for a block listing of ordinary shares to facilitate the admission of shares following option exercises under employee share schemes. This is a specific corporate action announcement related to share capital and listing rules, which falls under general regulatory announcements. Since it is a specific announcement (not a full report like 10-K or IR) and deals with share capital changes related to listing rules, it fits best under the general regulatory filing category (RNS) or potentially Share Issue/Capital Change (SHA). Given the context of an AIM listing rule compliance announcement ('Block Listing Application to AIM') and the explicit RNS branding, RNS is the most appropriate general classification for this type of regulatory news release that isn't a core financial report or a specific insider trade/dividend notice. The document length is short (3721 chars), suggesting it is an announcement rather than a comprehensive report.
2023-10-02 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.